🍂 Enjoy the Fall Season! 🍂
MindTheDesk

‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight

Top Story Archived • October 1, 2026 •
‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight
The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year.
Source: New York Post | https://nypost.com/feed/ - Read Original
"We build AI or anything ICST"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Network Cable Repairs from $29"